CompletedPhase 2NCT02247557

Intravesical Instillation of Liposome Encapsulated Botulinum Toxin A (Lipotoxin) in Treatment of Interstitial Cystitis

Studying Interstitial cystitis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Buddhist Tzu Chi General Hospital
Principal Investigator
Hann-Chorng Kuo, M.D.
Department of Urology, Buddihisst Tzu Chi General Hospital and Tzu Chi University
Intervention
Liposome encapsulated BoNT-A(drug)
Enrollment
90 target
Eligibility
20-80 years · All sexes
Timeline
20142017

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02247557 on ClinicalTrials.gov

Other trials for Interstitial cystitis

Additional recruiting or active studies for the same condition.

See all trials for Interstitial cystitis

← Back to all trials